Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “tacrolimus” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 22
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 22 pipeline programs matching "tacrolimus" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

22 results for “tacrolimus” Back to intelligence hub

Search results

  1. Tacrolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Transplantation

    phase 3 small molecule active

    1 trial
  2. Tacrolimus

    Takeda

    Ulcerative Colitis

    phase 3 small molecule terminated

    1 trial
  3. Tacrolimus

    Hospital Authority, Hong Kong

    Graft vs Host Disease

    phase 3 small molecule completed

    1 trial
  4. Tacrolimus BID

    Teva Pharma GmbH

    Medication Adherence

    phase 3 small molecule active

    1 trial
  5. Tacrolimus capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial
  6. Tacrolimus capsule

    Astellas Pharma Inc

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial
  7. Tacrolimus capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 small molecule completed

    1 trial
  8. tacrolimus

    Astellas Pharma Inc

    Kidney Transplantation

    phase 3 small molecule completed

    1 trial
  9. tacrolimus capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 small molecule terminated

    1 trial
  10. LP-10 (Liposomal Tacrolimus)

    LIPELLA PHARMACEUTICALS INC.

    Oral Lichen Planus

    phase 2 small molecule active

    1 trial
  11. Tacrolimus

    Astellas Pharma Inc

    Bone Marrow Transplantation

    phase 2 small molecule completed

    1 trial
  12. Tacrolimus ointment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma

    phase 2 small molecule active

    1 trial
  13. Tacrolimus

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial
  14. Tacrolimus

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  15. Tacrolimus

    Janssen-Cilag Pty Ltd

    Dermatitis, Atopic

    approved small molecule completed

    1 trial
  16. Tacrolimus sustained-release capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Renal Transplant Recipients

    approved small molecule completed

    1 trial
  17. cyclosporine or tacrolimus

    Wyeth is now a wholly owned subsidiary of Pfizer

    Graft Rejection

    approved small molecule completed

    1 trial
  18. tacrolimus

    Chinese University of Hong Kong

    Lupus Nephritis

    approved small molecule completed

    1 trial
  19. tacrolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Moderate/Severe Atopic Dermatitis

    approved small molecule completed

    1 trial
  20. Tacrolimus or Cyclosporine A

    The First People's Hospital of Lianyungang

    Immune Tolerance

    small molecule active

    1 trial
  21. Tacrolimus+Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    small molecule completed

    1 trial
  22. tacrolimus

    The First People's Hospital of Lianyungang

    Renal Transplantation

    small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.